- Home
- MREO vs RSF Comparison
MREO vs RSF Comparison
Compare MREO & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | RSF |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 61.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MREO | RSF |
|---|---|---|
| Price | $0.38 | $14.37 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.90 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 11.8K |
| Earning Date | 03-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,363.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.20 | $14.81 |
| 52 Week High | $3.05 | $16.23 |
Technical Indicators
Market Signals| Indicator | MREO | RSF |
|---|---|---|
| Relative Strength Index (RSI) | 32.09 | 43.66 |
| Support Level | $0.36 | $14.36 |
| Resistance Level | $0.44 | $14.55 |
| Average True Range (ATR) | 0.05 | 0.14 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 17.68 | 6.45 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.